{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:46:05Z","timestamp":1791431165453,"version":"4.3.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jaip.2017.02.013","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T15:30:47Z","timestamp":1490628647000},"page":"757-763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study"],"prefix":"10.1016","volume":"5","author":[{"given":"Emine","family":"Dibek Misirlioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Guvenir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semiha","family":"Bahceci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehtap","family":"Haktanir Abul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belgin Emine","family":"Usta Guc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Erkoco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Toyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmet Tekin","family":"Nacaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersoy","family":"Civelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Buyuktiryaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1939-3951","authenticated-orcid":false,"given":"Tayfur","family":"Ginis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazil","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can Naci","family":"Kocabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.02.013_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pcl.2013.12.001","article-title":"Cutaneous drug reactions in the pediatric population","volume":"61","author":"Noguera-Morel","year":"2014","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaip.2017.02.013_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/all.12774","article-title":"Drug hypersensitivity in children: report from the Pediatric Task Force of the EAACI Drug Allergy Interest Group","volume":"71","author":"Gomes","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.02.013_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7861\/clinmedicine.16-1-79","article-title":"Severe adverse drug reactions","volume":"16","author":"Teo","year":"2016","journal-title":"Clin Med"},{"key":"10.1016\/j.jaip.2017.02.013_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00281-015-0540-2","article-title":"Adverse cutaneous drug eruptions: current understanding","volume":"38","author":"Hoetzenecker","year":"2016","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaip.2017.02.013_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.29262\/ram.v61i1.16","article-title":"Prevalence of DRESS syndrome","volume":"61","author":"Lopez-Rocha","year":"2014","journal-title":"Rev Alerg Mex"},{"key":"10.1016\/j.jaip.2017.02.013_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000335627","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"97","author":"Harr","year":"2012","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.jaip.2017.02.013_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","article-title":"Acute generalized exanthematous pustulosis (AGEP): a review and update","volume":"73","author":"Szatkowski","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.mcna.2015.06.003","article-title":"Approach to the patient with a suspected cutaneous adverse drug reaction","volume":"99","author":"Swanson","year":"2015","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaip.2017.02.013_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP)\u2014a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jaip.2017.02.013_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1398-9995.2006.01136.x","article-title":"EAACI\/GA2LEN position paper: present status of the atopy patch test","volume":"61","author":"Turjanmaa","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.02.013_bib14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/ijd.13306","article-title":"The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions","volume":"5511","author":"Hassoun-Kheir","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2017.02.013_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.02.013_bib17","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2017.02.013_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The Euro SCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.alit.2015.09.001","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients\u2013treatment and outcome","volume":"65","author":"Yamane","year":"2016","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2017.02.013_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.aller.2015.02.004","article-title":"Severe delayed skin reactions related to drugs in the pediatric age group: a review of the subjects by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS)","volume":"44","author":"Belver","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2017.02.013_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.12788\/j.sder.0058","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: clinical patterns, diagnostic considerations, etiology, and therapeutic management","volume":"33","author":"Mockenhaupt","year":"2014","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaip.2017.02.013_bib22","first-page":"121","article-title":"A\u00a0systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children","volume":"18","author":"Del Pozzo-Magana","year":"2011","journal-title":"J\u00a0Popul Ther Clin Pharmacol"},{"key":"10.1016\/j.jaip.2017.02.013_bib23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","article-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"167","author":"Huang","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib25","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jdv.13212","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases","volume":"29","author":"Skowron","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2017.02.013_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5114\/ceji.2015.54606","article-title":"DRESS syndrome associated with type 2 diabetes in a child","volume":"40","author":"Erdem","year":"2015","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.jaip.2017.02.013_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2017.02.013_bib29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","article-title":"Risk factors for acute generalized exanthematous pustulosis (AGEP)\u2014results of a multinational case-control study (EuroSCAR)","volume":"157","author":"Sidoroff","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/bjd.13540","article-title":"Acute generalized exanthematous pustulosis: a retrospective audit of practice between 1994 and 2011 in a single center","volume":"172","author":"Ingen-Housz-Oro","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2017.02.013_bib31","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/bjd.12502","article-title":"Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients","volume":"169","author":"Hotz","year":"2013","journal-title":"Br J Dermatol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817301010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817301010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:14:26Z","timestamp":1761974066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817301010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213219817301010"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.02.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727460670.793576490","asserted-by":"object"}]},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}